South Africa has taken a monumental step in its fight against HIV with the registration of a long-acting prevention injection. The South African Health Products Regulatory Authority (SAHPRA) has announced the approval of the antiretroviral drug lenacapavir. Global health experts have hailed the twice-yearly jab as a “game-changer.” The prestigious journal Science named the injection, which provides six months of…